Clincosm LogoSign in Get a demo

Correlation of Clinical Frailty Scale and Modified Frailty Index in Intensive Care Patients

Sponsor
Diskapi Yildirim Beyazit Education and Research Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04515160
Collaborator
(none)
200
Enrollment
1
Location
18
Anticipated Duration (Months)
11.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of our study is to evaluate the correlation of the Clinical Frailty Scale, which is a judgment-based measure, and the Modified Frailty Index, which interrogates the patient's current diseases, in the frailty assessment of intensive care patients and the effect on the estimation of mortality, mechanical ventilation need, intensive care stay, hospital stay and discharge status.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Clinical Frailty Scale
  • Diagnostic Test: Modified Frailty Index

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
200 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Correlation of Clinical Frailty Scale and Modified Frailty Index in Intensive Care Patients
Actual Study Start Date :
Jul 1, 2020
Actual Primary Completion Date :
Jul 1, 2021
Anticipated Study Completion Date :
Jan 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Frailty [in the first 24 hours of intensive care admissions]

    the correlation of the Clinical Frailty Scale, which is a judgment-based measure, and the Modified Frailty Index, which interrogates the patient's current diseases, in the frailty assessment of intensive care patients

Secondary Outcome Measures

  1. mortality [the patient will be monitored for 1 year and the exitus time will be recorded]

    effect of the clinical frailty scale and modified farilty index on the estimation of mortality

  2. intensive care stay [the patient will be monitored for 1 year and the intensive care stay will be recorded]

    effect of the clinical frailty scale and modified farilty index on the estimation of intensive care stay

  3. discharge status [the patient will be monitored for 1 year and the discharge status will be recorded]

    effect of the clinical frailty scale and modified farilty index on the estimation of discharge status

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • intensive care patients
Exclusion Criteria:

  • patients with a life expectancy of less than 24 hours

  • Do not speak Turkish

Contacts and Locations

Locations

Site City State Country Postal Code
1 DiskapiYBERH Ankara Turkey

Sponsors and Collaborators

  • Diskapi Yildirim Beyazit Education and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bahar SAKIZCI UYAR, medical doctor, Diskapi Yildirim Beyazit Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT04515160
Other Study ID Numbers:
  • 92/04
First Posted:
Aug 17, 2020
Last Update Posted:
Sep 8, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Frailty

Study Results

No Results Posted as of Sep 8, 2021